Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: AIDS Care. 2019 Dec 2;32(11):1457–1461. doi: 10.1080/09540121.2019.1699643

Table 1.

Demographic Characteristics, HIV Testing and Seropositivity, STI Testing, HIV Risk Behaviour, and PrEP Behaviour and Understanding.

Full Sample
(n = 140)
n (%) or M (SD)
Sexually Active
(n = 110)
n (%) or M (SD)
Demographics
 Age (n = 139, n = 110) 22.76 (2.45) 22.79 (2.43)
 Gender
  Male 67 (47.9) 46 (41.8)
  Female 58 (41.4) 51 (46.4)
  Other gender identity 21 (15) 18 (16.4)
 Race and ethnicity
  Black 41 (29.3) 36 (32.7)
  Biracial, multiracial, biethnic, or multiethnic 37 (26.4) 25 (22.7)
  Hispanic or Latinx only 33 (23.6) 28 (25.5)
  White 11 (7.9) 7 (6.4)
  Other race and ethnicity 18 (12.9) 14 (12.7)
 Sexual orientation
 Heterosexual 78 (55.7) 60 (54.6)
 Gay or lesbian 24 (17.1) 19 (17.3)
 Bisexual or pansexual 23 (16.4) 21 (19.1)
 Other sexual orientation 15 (10.7) 10 (9.1)
 Education
  Less than high school 33 (23.6) 26 (23.6)
  High school or GED 69 (49.3) 56 (50.9)
  More than high school 38 (27.1) 28 (25.5)
 Age at first homeless experience (n = 139, n = 109) 17.13 (4.19) 17.1 (4.38)
 Housing tenure (n = 135, n = 106)
  3 months or less 27 (20.0) 22 (20.8)
  4–12 months 39 (28.9) 29 (27.4)
  1–2 years 51 (37.8) 41 (38.7)
  3 or more years 18 (13.3) 14 (13.2)
HIV risk behaviour
 Sexually active in past 3 months (n = 139) 110 (79.1) --
 Types of sexual activity (past 3 months)
  Unprotected vaginal or anal sex (n = 106) -- 67 (63.2)
  Unprotected vaginal or anal sex with non-serious partner (n = 106) -- 31 (29.3)
  Unprotected vaginal or anal sex with no HIV status talk before (n = 106) -- 25 (23.6)
  Sex under the influence half the time or more (n = 100) -- 30 (30.0)
  More than one partner in past 3 months (n = 99) -- 40 (40.4)
  Exchange sex (n = 105) -- 11 (10.5)
 Injection drug use ever (n = 125, n = 100) 3 (2.4) 3 (3.0)
 Injection drug use (past 30 days) 1 (0.8) 1 (1.0)
HIV testing (if never tested positive)
 Last HIV test (n = 133, n = 107)
  Past 3 months 57 (42.9) 50 (46.7)
  Past year 104 (78.2) 85 (79.4)
 Received posttest counselling at last test (n = 122, n = 100) 52 (42.6) 43 (43.0)
 Never received results of last HIV test 8 (6.6) 6 (6.0)
HIV seropositivity and treatment
 Self-reported HIV seropositivity (n = 139) 6 (4.3) 3 (2.7)
 Engagement in treatment (HIV+ sample only; n = 6)
  Currently seeing a doctor for HIV care 3 (50.0) 1 (33.3)
  Currently taking ARV medication 3 (50.0) 1 (33.3)
STI testing
 Tested in the past 3 months (n = 139, n = 109) 55 (39.6) 45 (41.3)
 Positive test (ever, among those tested; n = 115, n = 92)
  Chlamydia 25 (21.7) 22 (23.9)
  Gonorrhoea 15 (13.0) 12 (13.0)
  Herpes 6 (5.2) 5 (5.4)
  Genital warts or HPV 2 (1.7) 1 (1.1)
  Syphilis 8 (7.0) 6 (6.5)
Pre-exposure prophylaxis (PrEP)
 PrEP knowledge (n = 139, n = 109)
  Never heard of it 68 (48.9) 58 (53.2)
  Heard of it, but don’t know what it is 16 (11.5) 11 (10.1)
  Know a little bit 35 (25.2) 24 (22.0)
  Know a lot 20 (14.4) 16 (14.7)
 Source of PrEP knowledge (n = 140, n = 101)
  Doctor 30 (42.3) 25 (49.0)
  Counsellor or case worker 27 (38.0) 21 (41.2)
  Research study or intervention 21 (29.6) 15 (29.4)
  Advertisement 19 (26.8) 13 (25.5)
  Internet 16 (22.5) 11 (21.6)
  Friend 15 (21.1) 12 (23.5)
  Family member 7 (9.9) 5 (9.8)
  Sexual or romantic partner 7 (9.9) 5 (9.8)
  Other 5 (7.0) 1 (2.0)
 Been prescribed PrEP 9 (6.4) 6 (5.5)
 Currently taking PrEP (of those prescribed; n = 9, n = 6) 6 (66.7) 4 (66.7)
 Interest in taking PrEP (n = 115, n = 90) 48 (41.7) 38 (42.2)
 Perceived barriers to taking PrEP (n = 90, n = 68)
  Not at risk of HIV 52 (57.8) 39 (57.4)
  Concern about side effects 22 (24.4) 16 (23.5)
  Don’t know enough about it 19 (21.1) 12 (17.7)
  Too expensive 12 (13.3) 7 (10.3)
  Use other protection methods 11 (12.2) 10 (14.7)
  Don’t like taking any type of medication 9 (10.0) 5 (7.4)
  Too difficult to go to the doctor 6 (6.7) 2 (2.9)
  Too much effort to take daily pill 6 (6.7) 4 (5.9)
  Wouldn’t want anyone to know, stigma (n = 84, n = 63) 4 (4.8) 3 (4.8)